Andreas Ritzen,Morten Langgard,Jan Kehler,Jacob Nielsen,John Paul Kilburn,Mohamed M. Farah
申请号：
US14663706
公开号：
US20150190395A1
申请日:
2015.03.20
申请国别(地区):
US
年份:
2015
代理人:
摘要：
This invention is directed to compounds, which are PDE10A enzyme inhibitors. The invention provides a pharmaceutical composition comprising a therapeutically effective amount of a compound of the invention and a pharmaceutically acceptable carrier. The present invention also provides processes for the preparation of the compounds of formula I. The present invention further provides a method of treating a subject suffering from a neurodegenerative disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention also provides a method of treating a subject suffering from a drug addiction comprising administering to the subject a therapeutically effective amount of a compound of formula I. The present invention further provides a method of treating a subject suffering from a psychiatric disorder comprising administering to the subject a therapeutically effective amount of a compound of formula I.
